About the journal
Drugs - Real World Outcomes is an open-access journal published by Adis, Springer Healthcare in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,690 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 2199-1154 · 2198-9788
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,690 EUR
- Articles in DOAJ
- 296
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/40801
Index listings
- DOAJ · 2016-09-21
- Indexing
- DOAJ
- APC
- 2,690 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
296
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
555
Last recorded publication year
2026
h-index
33
i10-index
185
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2016-09-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 85%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Drugs real world outcomes
- Source type
- journal
- NLM unique ID (PubMed)
- 101658456
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
Show all subjects (50)
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Atrial Fibrillation Management and Outcomes
- Opioid Use Disorder Treatment
- Schizophrenia research and treatment
- Opioid Use Disorder Treatment
- Schizophrenia research and treatment
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Patient Safety and Medication Errors
- Patient Safety and Medication Errors
- Lung Cancer Treatments and Mutations
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Treatment of Major Depression
- Dementia and Cognitive Impairment Research
- Treatment of Major Depression
- Dementia and Cognitive Impairment Research
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Pharmaceutical studies and practices
- Lipoproteins and Cardiovascular Health
- Antimicrobial Resistance in Staphylococcus
- Drug-Induced Adverse Reactions
- Lipoproteins and Cardiovascular Health
- Antimicrobial Resistance in Staphylococcus
- Drug-Induced Adverse Reactions
- Intensive Care Unit Cognitive Disorders
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Intensive Care Unit Cognitive Disorders
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Diagnosis and Treatment
- Poisoning and overdose treatments
- Epilepsy research and treatment
- Epilepsy research and treatment
Keywords (DOAJ)
- big data
- drug utilization
- patient behaviour
- real world healthcare
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ